CME vs CPHI · P/E 22, rev $6.52B vs rev $4.1M
CME Group Inc (CME) versus China Pharma Holdings Inc (CPHI) — a side-by-side from cached financials, not a winner call.
CME Group Inc (CME) is a financial data & stock exchanges company listed on NASDAQ.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CME revenue for 2025-12-31 was $6.52B. Net income was $4.07B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. CME currently screens at market cap $91.25B and trailing P/E 21.9.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
CME currently screens at market cap $91.25B and trailing P/E 21.9. CPHI currently screens at market cap $29.0M.
Not investment advice. Open the CME and CPHI stock pages for the full models.
Not investment advice.